NewLink Genetics Surges 3% Following Ebola Contract News
December 22, 2014 at 09:32 AM EST
NewLink Genetics Corp (NASDAQ: NLNK) and Merck & Co., Inc. (NYSE: MRK) on Monday announced a contract for development of an Ebola ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.